Literature DB >> 2654616

[Differential diagnosis of increased phenylalanine blood level in infancy. Results of the German collaborative study on phenylketonuria (PKU)/hyperphenylalaninemia (HPA)].

H Schmidt, P Lutz, U Batzler.   

Abstract

Between 1978 and 1984 165 children with elevated Phe blood levels in newborn screening were included in a German multicentric study. The differential diagnosis, comprising Phe concentrations in the blood under a tetrahydrobiopterin (BH4) load (30 mg BH4), determination of pterins in the urine and dihydropteridin reductase (DHPR) in erythrocytes, resulted in two patients with a 6-pyruvoyltetrahydrobiopterin synthase (PTPS) deficiency. Those patients with a defect in the apoenzyme phenylalanine hydroxylase (PH) were treated with a low Phe diet, when the Phe blood concentrations exceeded 10 mg/dl under an adapted formula (n = 154). At the age of six months, in 155 infants a protein challenge containing 180 mg Phe/kg body weight for three days was performed, followed by a fourth day with 5 mg Phe/kg. Corresponding to the US Collaborative Study [19] 3 types of response were chosen according to the course of the Phe blood level under the challenge (n = 145). Type I response (n = 112) shows a continuous increase of the Phe more than 20 mg/dl even under the Phe restriction at day 4. Type II response (n = 14) shows also increasing Phe blood levels above 20 mg/dl, followed by a spontaneous decrease below 20 mg/dl still during the high Phe challenge and even lower at the fourth day with low Phe intake. Type III response (n = 19) had only a small increase of the Phe blood concentration, mostly below 15 mg/dl during the whole challenge period.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654616

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd        ISSN: 0026-9298            Impact factor:   0.323


  7 in total

1.  Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging.

Authors:  U Bick; G Fahrendorf; A C Ludolph; P Vassallo; J Weglage; K Ullrich
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

2.  Study design and description of patients.

Authors:  P Lutz; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

3.  Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.

Authors:  P Burgard; E Mönch; J Zschocke; U Wendel; U Langenbeck
Journal:  JIMD Rep       Date:  2015-12-19

4.  A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuria.

Authors:  U Langenbeck; A Behbehani; A Mench-Hoinowski
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

5.  Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

Authors:  U Wendel; K Ullrich; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

6.  Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age--Part 1.

Authors:  E Mönch; J Kneer; C Jakobs; M Arnold; H Diehl; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

7.  Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test.

Authors:  U Langenbeck; P Burgard; U Wendel; M Lindner; J Zschocke
Journal:  J Inherit Metab Dis       Date:  2009-07-16       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.